ACTU

Actuate Therapeutics
$1.15
−$0.03 (−2.54%)Jul 27, 2026
0.2PoorMoatMint rating

MoatMint rates Actuate Therapeutics (ACTU) 0.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.1 out of 10.

Key metrics

The numbers that frame ACTU today
Market cap
$27.51M
P/E (TTM)
-1.3
EV / FCF
-1.0
ROIC
372.9%
Div yield
0%
Debt / equity
0.0
52wk Low
$1.11
52wk High
$9.22

ACTU stock rating

How ACTU scores on quality, value, growth, momentum and financial health
0.2out of 10
Low overallNeutral business, expensive priceTop 98% of ~5,000 US stocks
QualityPoor0.1/10
GrowthNeutral4.4/10
MomentumPoor0.7/10
ValuePoor0.3/10
Financial HealthPoor1.5/10

Growth

Revenue and earnings trend for ACTU
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ACTU
Is Actuate Therapeutics a good buy?
No. Actuate Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Actuate Therapeutics is selling at a very high price.
What is the market capitalization of ACTU?
Actuate Therapeutics's market capitalization is $27.51M.
What is the P/E ratio for ACTU stock?
Actuate Therapeutics's current P/E ratio is -1.3.
What is the 52-week high for ACTU stock?
The 52-week high for Actuate Therapeutics is $9.22. The current close of $1.15 is 87.5% below that high.
What is the 52-week low for ACTU stock?
The 52-week low for Actuate Therapeutics is $1.11. The current close of $1.15 is 3.6% above that low.
Does ACTU stock pay dividends?
Actuate Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ACTU?
Actuate Therapeutics's Debt / Equity ratio is 0.